NEW! Investment Companies Centre

GlaxoSmithKline (GSK)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£57,405m

Change Today

Price Up2.00p (0.18%)

Share Price

1,103.50p

Regulatory News

Transaction in Own Shares 01-Dec-2008 18:07 RNS
Total Voting Rights 01-Dec-2008 16:59 RNS
Transaction in Own Shares 28-Nov-2008 16:56 RNS
Transaction in Own Shares 27-Nov-2008 17:05 RNS
Transaction in Own Shares 26-Nov-2008 17:28 RNS
Transaction in Own Shares 25-Nov-2008 17:09 RNS
Transaction in Own Shares 24-Nov-2008 17:25 RNS
Transaction in Own Shares 21-Nov-2008 17:25 RNS
Neptunus Joint Venture 21-Nov-2008 09:57 RNS
Transaction in Own Shares 20-Nov-2008 17:21 RNS
Acquisition of AstraZeneca Tika SNC 20-Nov-2008 14:38 RNS
Transaction in Own Shares 19-Nov-2008 17:25 RNS
Transaction in Own Shares 18-Nov-2008 16:55 RNS
Transaction in Own Shares 17-Nov-2008 17:15 RNS
Transaction in Own Shares 13-Nov-2008 16:57 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,103.50p Price Up
Change Today +2.00p
52 Week High 1,385.00
52 Week Low 995.00
Volume 6,549,631
Shares Issued 5,202m
Market Cap £57,405m
Beta 0.58
RiskGrade 257

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.48% below the market average93.48% below the market average93.48% below the market average93.48% below the market average93.48% below the market average
66.23% below the sector average66.23% below the sector average66.23% below the sector average66.23% below the sector average66.23% below the sector average
Price Trend
71.51% above the market average71.51% above the market average71.51% above the market average71.51% above the market average71.51% above the market average
68.18% above the sector average68.18% above the sector average68.18% above the sector average68.18% above the sector average68.18% above the sector average
Income
19.04% below the market average19.04% below the market average19.04% below the market average19.04% below the market average19.04% below the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
63.59% below the market average63.59% below the market average63.59% below the market average63.59% below the market average63.59% below the market average
83.1% below the sector average83.1% below the sector average83.1% below the sector average83.1% below the sector average83.1% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 11
Sell 3
Strong Sell 5
Total 26
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q3 Q2
Ex-Div 29-Oct-08 30-Jul-08
Paid 08-Jan-09 09-Oct-08
Amount 14.00p 13.00p

Trades for 02-Dec-2008

Time Volume / Share Price
14:27 589 @ 1,103.50p
14:27 589 @ 1,103.50p
14:27 589 @ 1,103.50p
14:27 2,484 @ 1,104.00p
14:27 1,449 @ 1,104.50p

GlaxoSmithKline Key Personnel

CFO Julian Heslop
CEO Andrew P Witty

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).